MedPath

Clinical Trial of bevacizumab in patients with retinopathy of prematurity

Phase 3
Recruiting
Conditions
retinopathy of prematurity
Registration Number
JPRN-jRCT2091220073
Lead Sponsor
obuhisa Naoi,MDDepartment of Ophthalmology,School of MedicineUniversity of Miyazaki
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria

Patients with retinopathy of prematurity admitted in Miyazaki University Hospital

Exclusion Criteria

none

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
retinal status
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath